Generation Bio Net Income 2020-2023 | GBIO
Generation Bio net income from 2020 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Generation Bio Annual Net Income
(Millions of US $) |
| 2023 |
$-127 |
| 2022 |
$-137 |
| 2021 |
$-119 |
| 2020 |
$-81 |
| 2019 |
$-61 |
Generation Bio Quarterly Net Income
(Millions of US $) |
| 2023-12-31 |
$-35 |
| 2023-09-30 |
$-28 |
| 2023-06-30 |
$-31 |
| 2023-03-31 |
$-32 |
| 2022-12-31 |
$-32 |
| 2022-09-30 |
$-31 |
| 2022-06-30 |
$-38 |
| 2022-03-31 |
$-35 |
| 2021-12-31 |
$-31 |
| 2021-09-30 |
$-32 |
| 2021-06-30 |
$-31 |
| 2021-03-31 |
$-26 |
| 2020-12-31 |
$-24 |
| 2020-09-30 |
$-21 |
| 2020-06-30 |
$-18 |
| 2020-03-31 |
$-18 |
| 2019-12-31 |
|
| 2019-09-30 |
$-16 |
| 2019-06-30 |
$-15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
